Table 1 Summary of the cell cycle and signaling alterations implicated in neurogenesis imbalances observed in animal models of depression and mediating the pro-neurogenic effects of antidepressant drugs and stimuli
Experimental model | Proliferation/neurogenesis in the hippocampal DG | Molecular changes | Reference |
|---|---|---|---|
Cell cycle regulators | |||
CUS exposed mice | ↓ | ↑ p27kip1 + cells in the SGZ of the DG | [64] |
Naïve mice chronically treated with fluoxetine, imipramine and desipramine | ↑ | ↓ p21cip expression in the SGZ of the DG | |
CMS exposed rats treated with venlafaxine, mirtazapine, and aripiprazole | (Not assessed) | ↑ Cdk5 activity and translocation of p35 activator to the membrane | [120] |
Signaling pathways | |||
Naïve animals chronically treated with fluoxetine | ↑ | ↑ Wnt3a expression | [124] |
Voluntary exercise in mice (antidepressant stimulus) | ↑ | ↑ Notch1 activity in DCX + cells (cell cycle exit promotion) | [132] |